Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada.

People living with HIV (PLHIV) often experience pain for which opioid medications may be prescribed. Thus, these individuals are particularly vulnerable to opioid-related harms, including overdose, misuse, and addiction, particularly when prescribed at high doses. We used a comprehensive linked popu...

Descripción completa

Detalles Bibliográficos
Publicado en:AIDS & Behavior Vol. 23; no. 12; pp. 3331 - 3340
Autores principales: Clark, Jessica, Fairbairn, Nadia, Nolan, Seonaid, Li, Tian, Wu, Anthony, Barrios, Rolando, Montaner, Julio, Ti, Lianping, the STOP HIV/AIDS in BC Study Group, Daly, Patty, Gustafson, Reka, Kendall, Perry R. W., Panessa, Ciro, Heath, Kate, Hogg, Robert S., Montaner, Julio S. G.
Formato: research tables/charts Journal Article
Publicado: Springer Nature Dec2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=139632715&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 139632715
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10907165
        G1T
      jtl: AIDS & Behavior
      issn: 10907165
      maglogo: N
    pubinfo:
      dt: Dec2019
      vid: 23
      iid: 12
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        139632715
        139632715
        144178817
        139632715
        10.1007/s10461-019-02589-3
        139632715
      ppf: 3331
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada.
      aug:
        au:
          Clark, Jessica
          Fairbairn, Nadia
          Nolan, Seonaid
          Li, Tian
          Wu, Anthony
          Barrios, Rolando
          Montaner, Julio
          Ti, Lianping
          the STOP HIV/AIDS in BC Study Group
          Daly, Patty
          Gustafson, Reka
          Kendall, Perry R. W.
          Panessa, Ciro
          Heath, Kate
          Hogg, Robert S.
          Montaner, Julio S. G.
        affil: Department of Medicine, University of British Columbia, 2775 Laurel Street, V5Z 1M9, Vancouver, BC, Canada
      sug:
        subj:
          Analgesics, Opioid Administration and Dosage
          Prescriptions, Drug
          HIV-Positive Persons British Columbia
          Prescribing Patterns
          British Columbia
          Analgesics, Opioid Adverse Effects
          Overdose Risk Factors
          Odds Ratio
          Confidence Intervals
          Morphine
          Antianxiety Agents, Benzodiazepine
          Substance Use Disorders
          Risk Assessment
          Attitude to AIDS
          Human
      ab: People living with HIV (PLHIV) often experience pain for which opioid medications may be prescribed. Thus, these individuals are particularly vulnerable to opioid-related harms, including overdose, misuse, and addiction, particularly when prescribed at high doses. We used a comprehensive linked population-level database of PLHIV in British Columbia (BC) to identify demographic and clinical characteristics associated with being prescribed any high-dose opioid analgesic, defined as > 90 daily morphine milligram equivalents (MME/day). Among PLHIV who were prescribed opioids between 1996 and 2015 (n = 10,780), 28.2% received prescriptions of > 90 MME/day at least once during the study period. Factors positively associated with being prescribed high-dose opioid analgesics included: co-prescription of benzodiazepines (adjusted odds ratio [AOR] = 1.14; 95% confidence interval 1.11–1.17); presence of an AIDS-defining illness (ADI; AOR = 1.78; 95% CI 1.57–2.02); seen by an HIV specialist (AOR = 1.24; 95% CI 1.20–1.29); substance use disorder (AOR = 1.46; 95% CI 1.25–1.71); and more recent calendar year (AOR = 1.05; 95% CI 1.04–1.06). Given the known risks associated with high-dose opioid prescribing, future research efforts should focus on the clinical indication and outcomes associated with these prescribing practices.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N